Blog

  • GSK shares fall as narrow approval of blood cancer drug limits US relaunch – Reuters

    1. GSK shares fall as narrow approval of blood cancer drug limits US relaunch  Reuters
    2. FDA delivers split decision on GSK’s blood cancer drug Blenrep, approving its use in some cases  statnews.com
    3. GSK’s Blenrep’s back in US, but with a narrower label  pharmaphorum
    4. Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD  AJMC
    5. Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma  Business Wire

    Continue Reading

  • Access Denied


    Access Denied

    You don’t have permission to access “http://www.business-standard.com/technology/tech-news/openai-acquires-software-applications-ai-startup-by-ex-apple-engineers-behind-workflow-shortcuts-125102400825_1.html” on this…

    Continue Reading

  • NatWest boss warns against higher bank taxes as lender’s profits rise 30% | NatWest Group

    NatWest boss warns against higher bank taxes as lender’s profits rise 30% | NatWest Group

    NatWest Group’s chief executive has warned the government against increasing taxes on banks in the autumn budget as the high street lender reported a 30% jump in profits.

    Paul Thwaite said he understood the “difficult choices” that the chancellor, Rachel Reeves, had to make in order to help close a potential £30bn shortfall in the public finances but argued she needed to “balance fiscal discipline” with “policies that create stability, consistency and support growth”.

    Twaite said on a call with journalists on Friday: “I think the government should be thoughtful about signals it sends to investors who are looking at the UK as a long-term home for capital.”

    His comments came as NatWest reported a strong jump in profits, which grew 30.4% to £2.18bn in the three months to the end of September, from £1.67bn during the same period last year.

    “My view remains that strong economies need strong banks, and I really want to use the capital of the bank to support our customers,” Thwaite said. “You can see in our numbers today, we’re providing a lot of capital to those who are buying houses or moving houses, a lot of capital to businesses … So I think it’s important that strong domestic banks are the backbone of the UK, and the best way to use our capital is to support customers.”

    The once bailed-out bank – which shed its final UK government stake earlier this year – said it was upping its full-year profitability and income guidance. It now expects income for 2025 to come in at £16.3bn, excluding notable items, solidifying previous forecasts for income greater than £16bn. Shares rose 2.9% on Friday morning, making the bank one of the biggest risers on the FTSE 100.

    Thwaite’s warnings come amid speculation over a number of potential tax increases, including on banks, property and landlords’ rental income, which could help the chancellor shore up the public finances in the budget on 26 November.

    Major UK bank stocks tumbled in August amid fears that the government could follow recommendations by the Institute for Public Policy Research, a thinktank, to introduce a new tax on the banking sector. That tax would help recover “windfalls” enjoyed by lenders as a result of an emergency economic policy known as quantitative easing that was put in place after the 2008 financial crisis.

    Thwaite echoed comments by high street bank peers including the Lloyds chief executive, Charlie Nunn, who previously said a rise in bank taxation “wouldn’t be consistent” with the chancellor’s overtures as the government pushes to reboot growth.

    skip past newsletter promotion

    Labour has placed financial services among its eight key sectors to receive government backing in its industrial strategy, while industry lobbyists have warned that the UK could lose business and make its financial services less competitive compared with other hubs including the US.

    Thwaite said: “I’ve been encouraged by what the chancellor and government have said and about how they see the role of financial services and banks in helping support that growth agenda. I do welcome those comments from NatWest’s perspective. I want us to play our part. Those messages have resonated well with investors. They have supported confidence in the sector.”

    Continue Reading

  • Can Max Verstappen beat the McLaren pair to the title based on current form?

    Can Max Verstappen beat the McLaren pair to the title based on current form?

    With five rounds remaining in the 2025 season, the battle for the Drivers’ Championship has been rapidly heating up.

    Much focus has surrounded the increased threat posed by Max Verstappen, with the Dutchman’s recent strong run of form seeing…

    Continue Reading

  • Development of high-throughput and efficient assay for central nervous

    Development of high-throughput and efficient assay for central nervous

    Introduction

    Central nervous system (CNS) infections encompass neuroinflammatory conditions triggered by pathogenic invasion of bacteria, viruses, fungi, or parasites into the brain, spinal cord, or meninges, with meningitis, encephalitis,…

    Continue Reading

  • Advances in science set to transform treatments for people living with dementia | Department for Science, Innovation & Technology

    Advances in science set to transform treatments for people living with dementia | Department for Science, Innovation & Technology

    From blood tests to AI, new ways to diagnose dementia sooner and treat it faster set to be unlocked by new research challenge.

    • From blood tests to AI, new ways to diagnose dementia sooner and treat it faster set to be unlocked by new…

    Continue Reading

  • F1 ACADEMY expands support for Champions of The Future Academy for 2026

    F1 ACADEMY expands support for Champions of The Future Academy for 2026

    F1 ACADEMY has announced the renewal and expansion of its support for global karting series Champions of The Future Academy (COTFA), with up to 27 young female drivers set to be supported by F1 ACADEMY DISCOVER YOUR DRIVE in 2026.

    Since its…

    Continue Reading

  • Using bugs to tame urate and advance gout prevention

    Using bugs to tame urate and advance gout prevention

    EIC Bugs4Urate project pioneers living therapies and personalised nutrition to transform early gout prevention and metabolic health.

    For centuries, gout has carried an almost mythical image: swollen joints, excruciating pain, and an unfair link…

    Continue Reading

  • Procter & Gamble (PG) Q1 2026 earnings

    Procter & Gamble (PG) Q1 2026 earnings

    Boxes of Tide Pods dishwasher detergent are displayed at a Costco Wholesale store on July 12, 2025 in San Diego, California.

    Kevin Carter | Getty Images News | Getty Images

    Procter & Gamble on Friday reported fiscal first-quarter earnings and revenue that beat analysts’ expectations, lifted by higher demand for its beauty and grooming products.

    However, the company warned that it expects higher costs from tariffs in fiscal 2026, which began in July. Despite what CEO Jon Moeller called a “challenging consumer and geopolitical environment,” P&G reiterated its forecast for all-in sales and earnings for the fiscal year.

    Shares of the company rose about 2% in premarket trading.

    Here’s what the company reported for the quarter ended Sept. 30 compared with what Wall Street was expecting, based on a survey of analysts by LSEG:

    • Earnings per share: $1.99 adjusted vs. $1.90 expected
    • Revenue: $22.39 billion vs. $22.18 billion expected

    P&G reported fiscal first-quarter net income attributable to the company of $4.75 billion, or $1.95 per share, up from $3.96 billion, or $1.61 per share, a year earlier.

    Excluding items, including costs associated with incremental restructuring, the consumer giant earned $1.99 per share.

    Net sales rose 3% to $22.39 billion. Organic sales, which strips out the impact of acquisitions, divestitures and foreign currency, increased 2% in the quarter

    P&G’s volume was flat compared with the year-ago period. Volume excludes pricing, which makes it a more accurate reflection of demand than sales.

    This story is developing. Please check back for updates.

    Continue Reading

  • P&G Announces Fiscal Year 2026 First Quarter Results

    Net Sales +3%; Organic Sales +2%

    Diluted EPS $1.95, +21%; Core EPS $1.99, +3%

    MAINTAINS FISCAL YEAR SALES, EPS GROWTH AND CASH RETURN GUIDANCE

    CINCINNATI–(BUSINESS WIRE)–The Procter & Gamble Company (NYSE:PG) reported first quarter fiscal year 2026 net sales of $22.4 billion, an increase of three percent versus the prior year. Organic sales, which excludes the impacts of foreign exchange and acquisitions and divestitures, increased two percent versus the prior year. Diluted net earnings per share were $1.95, an increase of 21% versus the prior year primarily due to higher non-core restructuring charges in the prior year. Core earnings per share were $1.99, an increase of three percent versus the prior year.

    Operating cash flow was $5.4 billion, and net earnings were $4.8 billion for the quarter. Adjusted free cash flow productivity was 102%. Adjusted free cash flow productivity is calculated as operating cash flow less capital spending and certain other items, as a percentage of net earnings. The Company returned $3.8 billion of cash to shareowners via $2.55 billion of dividend payments and $1.25 billion of share repurchases.

    First Quarter ($ billions, except EPS)

    GAAP

    2026

    2025

    % Change

     

    Non-GAAP*

    2026

    2025

    % Change

    Net Sales

    22.4

    21.7

    3%

     

    Organic Sales

    n/a

    n/a

    2%

    Diluted EPS

    1.95

    1.61

    21%

     

    Core EPS

    1.99

    1.93

    3%

    *Please refer to Exhibit 1 – Non-GAAP Measures for the definition and reconciliation of these measures to the related GAAP measures. 

    “Our organic sales growth, earnings and cash results in the first quarter reflect strong execution of our integrated strategy,” said Jon Moeller, Chairman of the Board, President and Chief Executive Officer. “These results keep us on track to deliver within our guidance ranges on all key financial metrics for the fiscal year in a challenging consumer and geopolitical environment. We remain committed to our integrated growth strategy of a focused product portfolio of daily use categories where performance drives brand choice, superiority — across product performance, packaging, brand communication, retail execution and consumer and customer value — productivity, constructive disruption and an agile and accountable organization. We are increasing investment in innovation and demand creation to improve value for consumers and drive category growth.”

    July – September Quarter Discussion

    Net sales in the first quarter of fiscal year 2026 were $22.4 billion, a three percent increase versus the prior year. Organic sales, which exclude the impacts of foreign exchange and acquisitions and divestitures, increased two percent driven by a one percent increase from higher pricing and a one percent increase from favorable mix. Organic volume had a neutral impact on sales for the quarter.

    July – September 2025

    Volume

    Foreign

    Exchange

    Price

    Mix

    Other (2)

    Net Sales

    Organic

    Volume

    Organic

    Sales

    Net Sales Drivers (1)

    Beauty

    4%

    1%

    2%

    (1)%

    —%

    6%

    4%

    6%

    Grooming

    1%

    2%

    4%

    (2)%

    —%

    5%

    1%

    3%

    Health Care

    (2)%

    1%

    1%

    2%

    —%

    2%

    (2)%

    1%

    Fabric & Home Care

    (2)%

    2%

    1%

    —%

    —%

    1%

    (2)%

    —%

    Baby, Feminine & Family Care

    —%

    1%

    —%

    —%

    —%

    1%

    —%

    —%

    Total P&G

    —%

    1%

    1%

    1%

    —%

    3%

    —%

    2%

     

    (1) Net sales percentage changes are approximations based on quantitative formulas that are consistently applied. 

    (2) Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.  

    • Beauty segment organic sales increased six percent versus year ago. Hair Care organic sales increased low single-digits driven by volume increases and innovation-driven pricing in North America and Europe, partially offset by unfavorable geographic and product mix. Personal Care organic sales increased high single digits due to innovation-driven volume growth and pricing in North America, partially offset by negative impacts from geographic mix. Skin Care organic sales increased mid-single digits due to favorable premium product mix and higher pricing primarily in North America, partially offset by volume declines.
    • Grooming segment organic sales increased three percent versus year ago behind innovation-driven pricing, primarily in North America and Europe, and volume growth, partially offset by unfavorable product mix.
    • Health Care segment organic sales increased one percent versus year ago. Oral Care organic sales were unchanged as product mix from premium innovation was offset by volume declines. Personal Health Care organic sales increased low single digits due to higher pricing, primarily in Latin America and North America, partially offset by volume declines.
    • Fabric and Home Care segment organic sales were unchanged versus year ago. Fabric Care organic sales decreased low single digits driven by volume declines mainly in Europe. Home Care organic sales increased low single digits driven by higher pricing, primarily in North America and Europe, partially offset by volume declines, primarily in Europe.
    • Baby, Feminine and Family Care segment organic sales were unchanged versus year ago. Baby Care organic sales increased low single digits due to favorable premium product mix and a unit volume increase. Feminine Care organic sales were unchanged as the positive impacts of favorable product mix and innovation-driven pricing, primarily in North America, were offset by volume declines. Family Care organic sales decreased low single digits driven by merchandising investments.

    Diluted net earnings per share increased by 21% to $1.95, driven primarily by higher restructuring charges related to the substantial liquidation of operations in certain Enterprise Markets, including Argentina, in the prior year period. Core earnings per share and currency-neutral core EPS increased three percent to $1.99.

    Reported gross margin for the quarter decreased 70 basis points versus the prior year. Core gross margin for the quarter decreased 50 basis points versus the prior year and on a currency-neutral basis decreased 30 basis points. Benefits from gross productivity savings of 140 basis points, increased pricing of 50 basis points and 20 basis points of rounding and other items were more than offset by 100 basis points of unfavorable mix, 70 basis points of product reinvestments and 70 basis points of higher costs from tariffs and commodities.

    Reported selling, general and administrative expense (SG&A) as a percentage of sales declined 20 basis points versus year ago. Core SG&A as a percentage of sales decreased 40 basis points versus year ago and decreased 70 basis points on a currency-neutral basis. The decline was driven by 90 basis points of productivity savings, 40 basis points of net sales growth leverage and 10 basis points of rounding and other items, partially offset by 70 basis points of reinvestments.

    Reported operating margin for the quarter decreased 50 basis points versus the prior year. Core operating margin for the quarter was unchanged versus the prior year and increased 40 basis points on a currency-neutral basis. Core operating margin included gross productivity savings of 230 basis points.

    Fiscal Year 2026 Guidance

    P&G maintained its guidance range for fiscal 2026 all-in sales growth to be in the range of one to five percent versus the prior year. The net impacts of foreign exchange rates and acquisitions and divestitures are expected to be a tailwind of approximately one percentage point to all-in sales growth. The Company also maintained its outlook for organic sales growth in the range of in-line to up four percent versus the prior year.

    P&G maintained its fiscal 2026 diluted net earnings per share growth to be in the range of 3% to 9% versus fiscal 2025 diluted net EPS of $6.51. P&G also maintained its fiscal 2026 core earnings per share growth to be in the range of in-line to up four percent versus fiscal 2025 core EPS of $6.83. This outlook equates to a range of $6.83 to $7.09 per share, with a mid-point estimate of $6.96, or an increase of 2%.

    P&G now expects a commodity cost headwind of approximately $100 million after tax and higher costs from tariffs of approximately $400 million after tax for fiscal 2026. The Company continues to expect a net headwind of roughly $250 million after-tax from modestly higher net interest expense and a higher core effective tax rate versus the prior year. The Company also continues to expect favorable foreign exchange rates will be a tailwind of approximately $300 million after tax. Collectively these impacts equate to a headwind of $0.19 per share for fiscal 2026.

    The Company is unable to reconcile its forward-looking non-GAAP cash flow and tax rate measures without unreasonable efforts given the unpredictability of the timing and amounts of discrete items, such as acquisitions, divestitures, or impairments, which could significantly impact GAAP results.

    P&G continues to expect a core effective tax rate to be in the range of 20% to 21% in fiscal 2026.

    Capital spending is estimated to be in the range of four to five percent of fiscal 2026 net sales.

    P&G continues to expect adjusted free cash flow productivity of 85% to 90% and expects to pay around $10 billion in dividends and to repurchase approximately $5 billion of common shares in fiscal 2026.

    Forward-Looking Statements

    Certain statements in this release, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result” and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, except to the extent required by law.

    Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, changes in global interest rates and rate differentials, currency exchange, pricing controls or tariffs; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to effect the expected share repurchases and dividend payments; (3) the ability to successfully manage uncertainties related to changing political and geopolitical conditions and potential implications such as exchange rate fluctuations, market contraction, boycotts, variability and unpredictability in trade relations, sanctions, tariffs or other trade controls; (4) the ability to manage disruptions in credit markets or to our banking partners or changes to our credit rating; (5) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to various factors, including ones outside of our control, such as natural disasters, acts of war or terrorism or disease outbreaks; (6) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials and costs of labor, transportation, energy, pension and healthcare; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy, packaging content, supply chain practices, social or environmental practices or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, contract manufacturers, distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third-party information and operational technology systems, networks and services and maintain the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage the demand, supply and operational challenges, as well as governmental responses or mandates, associated with a disease outbreak, including epidemics, pandemics or similar widespread public health concerns; (13) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits, evolving digital marketing and selling platform requirements and technological advances attained by, and patents granted to, competitors; (14) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company’s overall business strategy and financial objectives, without impacting the delivery of base business objectives; (15) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited; (16) the ability to successfully manage current and expanding regulatory and legal requirements and matters (including, without limitation, those laws, regulations, policies and related interpretations involving product liability, product and packaging composition, manufacturing processes, intellectual property, labor and employment, antitrust, privacy, cybersecurity, data protection and data transfers, artificial intelligence, tax, the environment, due diligence, risk oversight, accounting and financial reporting) and to resolve new and pending matters within current estimates; (17) the ability to manage changes in applicable tax laws and regulations; and (18) the ability to continue delivering progress towards our environmental sustainability ambitions.

    For additional information concerning factors that could cause actual results and events to differ materially from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports.

    About Procter & Gamble

    P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news.

     
     
     

    THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

    Consolidated Earnings Information

     

    Three Months Ended September 30

    Amounts in millions except per share amounts

     

    2025

     

     

     

    2024

     

     

    % Chg

    NET SALES

    $

    22,386

     

     

    $

    21,737

     

     

    3%

    Cost of products sold

     

    10,887

     

     

     

    10,421

     

     

    4%

    GROSS PROFIT

     

    11,499

     

     

     

    11,316

     

     

    2%

    Selling, general and administrative expense

     

    5,643

     

     

     

    5,519

     

     

    2%

    OPERATING INCOME

     

    5,856

     

     

     

    5,797

     

     

    1%

    Interest expense

     

    (197

    )

     

     

    (238

    )

     

    (17)%

    Interest income

     

    108

     

     

     

    135

     

     

    (20)%

    Other operating income/(expense), net

     

    268

     

     

     

    (554

    )

     

    (148)%

    EARNINGS BEFORE INCOME TAXES

     

    6,034

     

     

     

    5,140

     

     

    17%

    Income taxes

     

    1,253

     

     

     

    1,152

     

     

    9%

    NET EARNINGS

     

    4,781

     

     

     

    3,987

     

     

    20%

    Less: Net earnings attributable to noncontrolling interests

     

    31

     

     

     

    28

     

     

    11%

    NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE

    $

    4,750

     

     

    $

    3,959

     

     

    20%

     

     

     

     

     

     

    EFFECTIVE TAX RATE

     

    20.8

    %

     

     

    22.4

    %

     

     

     

     

     

     

     

     

    NET EARNINGS PER COMMON SHARE (1)

     

     

     

     

     

    Basic

    $

    2.00

     

     

    $

    1.65

     

     

    21%

    Diluted

    $

    1.95

     

     

    $

    1.61

     

     

    21%

     

     

     

     

     

     

    DIVIDENDS PER COMMON SHARE

    $

    1.0568

     

     

    $

    1.0065

     

     

     

    DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING

     

    2,436.8

     

     

     

    2,466.0

     

     

     

     

     

     

     

     

     

    COMPARISONS AS A % OF NET SALES

     

     

     

     

    Basis Pt Chg

    Gross profit

     

    51.4%

     

     

    52.1%

     

    (70)

    Selling, general and administrative expense

     

    25.2%

     

     

    25.4%

     

    (20)

    Operating income

     

    26.2%

     

     

    26.7%

     

    (50)

    Earnings before income taxes

     

    27.0%

     

     

    23.6 %

     

    340

    Net earnings

     

    21.4%

     

     

    18.3%

     

    310

    Net earnings attributable to Procter & Gamble

     

    21.2%

     

     

    18.2%

     

    300

     

    (1) Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble. 

     

    Certain columns and rows may not add due to rounding.

     
     
     
     

    THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

    Consolidated Earnings Information

     

    Three Months Ended September 30, 2025

    Amounts in millions

    Net Sales

     

    % Change

    Versus Year

    Ago

     

    Earnings/(Loss)

    Before

    Income Taxes

     

    % Change

    Versus Year

    Ago

     

    Net Earnings

     

    % Change

    Versus Year

    Ago

    Beauty

    $

    4,143

     

    6%

     

    $

    1,132

     

     

    6%

    $

    879

     

    5%

    Grooming

     

    1,817

     

    5%

     

     

    585

     

     

    12%

     

    463

     

    9%

    Health Care

     

    3,220

     

    2%

     

     

    937

     

     

    (2)%

     

    718

     

    (3)%

    Fabric & Home Care

     

    7,793

     

    1%

     

     

    2,042

     

     

    (2)%

     

    1,579

     

    (3)%

    Baby, Feminine & Family Care

     

    5,171

     

    1%

     

     

    1,446

     

     

    5%

     

    1,105

     

    4%

    Corporate

     

    242

     

    N/A

     

     

    (108

    )

     

    N/A

     

    36

     

    N/A

    Total Company

    $

    22,386

     

    3%

     

    $

    6,034

     

     

    17%

    $

    4,781

     

    20%

     

    Three Months Ended September 30, 2025

    Net Sales Drivers (1)

    Volume

     

    Organic

    Volume

     

    Foreign

    Exchange

     

    Price

     

    Mix

     

    Other (2)

     

    Net Sales

    Beauty

    4%

     

    4%

     

    1%

     

    2%

     

    (1)%

     

    —%

     

    6%

    Grooming

    1%

     

    1%

     

    2%

     

    4%

     

    (2)%

     

    —%

     

    5%

    Health Care

    (2)%

     

    (2)%

     

    1%

     

    1%

     

    2%

     

    —%

     

    2%

    Fabric & Home Care

    (2)%

     

    (2)%

     

    2%

     

    1%

     

    —%

     

    —%

     

    1%

    Baby, Feminine & Family Care

    —%

     

    —%

     

    1%

     

    —%

     

    —%

     

    —%

     

    1%

    Total Company

    —%

     

    —%

     

    1%

     

    1%

     

    1%

     

    —%

     

    3%

     

    (1) Net sales percentage changes are approximations based on quantitative formulas that are consistently applied. 

    (2) Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales. 

     

    Certain columns and rows may not add due to rounding.

     
     
     
     

    THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

    Consolidated Statements of Cash Flows

     

    Three Months Ended September 30

    Amounts in millions

     

    2025

     

     

     

    2024

     

    CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD

    $

    9,556

     

     

    $

    9,482

     

    OPERATING ACTIVITIES (1)

     

     

     

    Net earnings

     

    4,781

     

     

     

    3,987

     

    Depreciation and amortization

     

    761

     

     

     

    728

     

    Share-based compensation expense

     

    121

     

     

     

    105

     

    Deferred income taxes

     

    53

     

     

     

    184

     

    Loss/(gain) on sale of assets

     

    (3

    )

     

     

    794

     

    Change in accounts receivable

     

    (305

    )

     

     

    (134

    )

    Change in inventories

     

    (303

    )

     

     

    (188

    )

    Change in accounts payable

     

    648

     

     

     

    90

     

    Other

     

    (344

    )

     

     

    (1,264

    )

    TOTAL OPERATING ACTIVITIES

     

    5,408

     

     

     

    4,302

     

    INVESTING ACTIVITIES

     

     

     

    Capital expenditures

     

    (1,200

    )

     

     

    (993

    )

    Proceeds from asset sales

     

    8

     

     

     

    45

     

    Acquisitions, net of cash acquired

     

    (5

    )

     

     

    (6

    )

    Other investing activity

     

    (338

    )

     

     

    (154

    )

    TOTAL INVESTING ACTIVITIES

     

    (1,535

    )

     

     

    (1,108

    )

    FINANCING ACTIVITIES

     

     

     

    Dividends to shareholders

     

    (2,549

    )

     

     

    (2,445

    )

    Additions to short-term debt with original maturities of more than three months

     

    1,123

     

     

     

    4,090

     

    Reductions in short-term debt with original maturities of more than three months

     

    (1,800

    )

     

     

    (571

    )

    Net additions/(reductions) to other short-term debt

     

    2,108

     

     

     

    (444

    )

    Reductions in long-term debt

     

    (3

    )

     

     

    (70

    )

    Treasury stock purchases

     

    (1,250

    )

     

     

    (1,939

    )

    Impact of stock options and other

     

    134

     

     

     

    745

     

    TOTAL FINANCING ACTIVITIES

     

    (2,239

    )

     

     

    (634

    )

    EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH

     

    (20

    )

     

     

    116

     

    CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH

     

    1,615

     

     

     

    2,675

     

    CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD

    $

    11,171

     

     

    $

    12,156

     

     

    (1) Certain prior period amounts within Operating Activities have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the previously reported Total Operating Activities. 

     

    Certain columns and rows may not add due to rounding.

     
     
     
     

    THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

    Condensed Consolidated Balance Sheets

    Amounts in millions

    September 30, 2025

     

    June 30, 2025

    Cash and cash equivalents

    $

    11,171

     

    $

    9,556

    Accounts receivable

     

    6,487

     

     

    6,185

    Inventories

     

    7,848

     

     

    7,551

    Prepaid expenses and other current assets

     

    1,612

     

     

    2,100

    TOTAL CURRENT ASSETS

     

    27,118

     

     

    25,392

    Property, plant and equipment, net

     

    24,119

     

     

    23,897

    Goodwill

     

    41,643

     

     

    41,650

    Trademarks and other intangible assets, net

     

    21,818

     

     

    21,910

    Other noncurrent assets

     

    12,901

     

     

    12,381

    TOTAL ASSETS

    $

    127,599

     

    $

    125,231

     

     

     

     

    Accounts payable

    $

    15,609

     

    $

    15,227

    Accrued and other liabilities

     

    10,756

     

     

    11,318

    Debt due within one year

     

    11,631

     

     

    9,513

    TOTAL CURRENT LIABILITIES

     

    37,995

     

     

    36,058

    Long-term debt

     

    24,315

     

     

    24,995

    Deferred income taxes

     

    5,893

     

     

    5,774

    Other noncurrent liabilities

     

    5,844

     

     

    6,120

    TOTAL LIABILITIES

     

    74,048

     

     

    72,946

    TOTAL SHAREHOLDERS’ EQUITY

     

    53,551

     

     

    52,284

    TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

    $

    127,599

     

    $

    125,231

     

    Certain columns and rows may not add due to rounding. 

     
     
     

    The Procter & Gamble Company

    Exhibit 1: Non-GAAP Measures

    The following provides definitions of the non-GAAP measures used in Procter & Gamble’s October 24, 2025 earnings release and the reconciliation to the most closely related GAAP measures. We believe that these measures provide useful perspective on underlying business trends (i.e., trends excluding non-recurring or unusual items) and results and provide a supplemental measure of period-to-period results. The non-GAAP measures described below are used by management in making operating decisions, allocating financial resources and for business strategy purposes. These measures may be useful to investors, as they provide supplemental information about business performance and provide investors a view of our business results through the eyes of management. Certain of these measures are also used to evaluate senior management and are a factor in determining their at-risk compensation. These non-GAAP measures are not intended to be considered by the user in place of the related GAAP measures but rather as supplemental information to our business results. These non-GAAP measures may not be the same as similar measures used by other companies due to possible differences in method and in the items or events being adjusted. The Company is not able to reconcile its forward-looking non-GAAP cash flow and tax rate measures because the Company cannot predict the timing and amounts of discrete items such as acquisition and divestitures, which could significantly impact GAAP results. Note that certain columns and rows may not add due to rounding.

    The Core earnings measures included in the following reconciliation tables refer to the equivalent GAAP measures adjusted as applicable for the following item:

    • Incremental restructuring: The Company has historically had an ongoing level of restructuring activities of approximately $250 – $500 million before tax.

    Contacts

    P&G Media Contacts:
    Wendy Kennedy, 513.780.7212

    Henry Molski, 513.505.3587

    P&G Investor Relations Contact:
    John Chevalier, 513.983.9974

    Read full story here

    Continue Reading